A detailed history of Monaco Asset Management Sam transactions in Galapagos Nv stock. As of the latest transaction made, Monaco Asset Management Sam holds 20,999 shares of GLPG stock, worth $561,933. This represents 0.09% of its overall portfolio holdings.

Number of Shares
20,999
Previous 20,999 -0.0%
Holding current value
$561,933
Previous $520,000 16.15%
% of portfolio
0.09%
Previous 0.08%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$24.78 - $32.48 $105,438 - $138,202
4,255 Added 25.41%
20,999 $520,000
Q1 2024

May 09, 2024

BUY
$32.2 - $42.44 $322,000 - $424,400
10,000 Added 148.28%
16,744 $539,000
Q4 2023

Feb 07, 2024

SELL
$31.87 - $40.71 $54,625 - $69,776
-1,714 Reduced 20.26%
6,744 $274,000
Q3 2023

Nov 07, 2023

BUY
$34.17 - $42.98 $10,695 - $13,452
313 Added 3.84%
8,458 $292,000
Q2 2023

Aug 08, 2023

SELL
$37.4 - $44.52 $597,465 - $711,207
-15,975 Reduced 66.23%
8,145 $331,000
Q1 2023

May 11, 2023

BUY
$36.5 - $48.0 $198,633 - $261,216
5,442 Added 29.14%
24,120 $931,000
Q4 2022

Jan 31, 2023

BUY
$37.44 - $46.51 $324,904 - $403,613
8,678 Added 86.78%
18,678 $829,000
Q3 2022

Oct 31, 2022

BUY
$42.27 - $57.6 $422,700 - $576,000
10,000 New
10,000 $426,000
Q2 2022

Aug 01, 2022

SELL
$52.3 - $71.59 $889,100 - $1.22 Million
-17,000 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$51.32 - $68.5 $4.11 Million - $5.48 Million
-80,064 Reduced 82.49%
17,000 $1.05 Million
Q4 2021

Feb 04, 2022

BUY
$47.03 - $57.12 $4.56 Million - $5.54 Million
97,064 New
97,064 $5.35 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.76B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.